Elon Musk's Neuralink Initiates Brain Implant Study, Aims To Enroll 3 Patients For Revolutionary Digital Control
Benzinga
2024-05-29
Views 56
Neuralink, the brain-chip company founded by Elon Musk, is seeking to evaluate its device in a clinical trial. The study, which is anticipated to conclude in 2031, aims to test the implant’s potential to enable paralyzed patients to operate digital devices using their thoughts, Reuters reported.
Report form
RELATED VIDEOS
